Literature DB >> 7511941

Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview.

S Nelson1.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) regulates the production and potentiates the function of neutrophils. Studies of animals and patients have shown that levels of G-CSF increase in response to certain types of acute bacterial infection; for example, levels of this factor increase in the lungs and in serum during pneumonia. Investigations of several nonneutropenic animal models of severe bacterial infection have indicated that exogenous recombinant G-CSF--either alone or in combination with antibiotics--can significantly enhance host defenses and improve rates of survival. Trials of recombinant G-CSF for the prevention or treatment of serious infection in clinical settings have recently been initiated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511941     DOI: 10.1093/clinids/18.supplement_2.s197

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Green fluorescent protein labeling Escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy.

Authors:  Desheng Song; Bin Shi; Hua Xue; Yousheng Li; Baojun Yu; Zhe Xu; Fukun Liu; Jieshou Li
Journal:  Curr Microbiol       Date:  2005-12-26       Impact factor: 2.188

2.  Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit model.

Authors:  U Frank; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.

Authors:  F de Lalla; G Pellizzer; M Strazzabosco; Z Martini; G Du Jardin; L Lora; P Fabris; P Benedetti; G Erle
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 4.  Hematopoietic growth factors in cancer patients with invasive fungal infections.

Authors:  F Offner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

5.  Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate.

Authors:  Desheng Song; Bin Shi; Hua Xue; Yousheng Li; Xiaodong Yang; Baojun Yu; Zhe Xu; Fukun Liu; Jieshou Li
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

Review 6.  Role of cytokines in pulmonary antimicrobial host defense.

Authors:  B Mehrad; T J Standiford
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 7.  Alcohol abuse and pulmonary disease.

Authors:  Darren M Boé; R William Vandivier; Ellen L Burnham; Marc Moss
Journal:  J Leukoc Biol       Date:  2009-07-14       Impact factor: 4.962

8.  Diagnostic value of blood cytokine concentrations in acute pneumonia.

Authors:  P Kragsbjerg; I Jones; T Vikerfors; H Holmberg
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

9.  Effects of granulocyte-colony stimulating factor on peritoneal defense mechanisms and bacterial translocation after administration of systemic chemotherapy in rats.

Authors:  Celal Cerci; Cagri Ergin; Erol Eroglu; Canan Agalar; Fatih Agalar; Sureyya Cerci; Mahmut Bulbul
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

10.  Granulocyte stimulating factor in patients on peritoneal dialysis and LPS stimulated peripheral blood mononuclear cells.

Authors:  A Brauner; B Hylander; Y Lu
Journal:  Inflammation       Date:  1998-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.